With a special focus on aesthetics, the September issue of the Journal of Drugs in Dermatology features an outstanding editorial line-up with original articles, features and case reports on topics ranging from soft tissue fillers, non-surgical eyebrow rejuvenation, new topical treatment for keloid scars to mask use during the COVID-19 pandemic causing undesirable post-operative complications and everything in between! Straight from the JDD Editor’s desk, we share this month’s issue highlights:
A literature review followed by panel discussions aimed to answer questions related to tailoring skincare in Racial/Ethnic Variations in Skin Barrier: Implications for Skin Care Recommendations in Skin of Color
Results showed homogeneous dermal integration in Clinical Validation of Superficial Lip Injections Utilizing Cohesive Polydensified Matrix Hyaluronic Acid-Based Soft Tissue Fillers
Aesthetic improvement and subject satisfaction were high and lasted through week 48 in A Randomized, Comparator-Controlled Study of HARC for Cheek Augmentation and Correction of Midface Contour Deficiencies Beyond Muscle: A Narrative Review of Onabotulinum Toxin A for Skin Quality
A Randomized, Double-Blind, Active- and Placebo-Controlled Trial Evaluating a Novel Topical Treatment for Keloid Scars investigates a potentially new and effective treatment for mature keloid scars.
Authors aim to highlight various minimally invasive rejuvenation techniques in Non-Surgical Eyebrow Rejuvenation Techniques: A Review
Efficacy and safety are evaluated in AbobotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines: A Randomized, Dose-Escalating, Double-Blind Study
Increasing the reconstitution and injection volumes could provide more options in AbobotulinumtoxinA Treatment of Glabellar Lines Using a New Reconstitution and Injection Volume: Randomized, Placebo-Controlled Data
Novel Vitamin C and E and Green Tea Polyphenols Combination Serum Improves Photoaged Facial Skin assesses safety, tolerability, and efficacy.
Diversity in Dermatology: Dermatology Resident Exposure to Skin of Color evaluates current trends in SOC residency curricula and assesses confidence in caring for SOC patient population.
While it is important for physicians to participate in advocacy and policymaking, their perceived ability to do so is limited by knowledge gaps in Health Policy Education in U.S. Dermatology Residency Programs: A Nationwide Survey of Program Leadership
Cases of compromised wound healing are reported in Mask Use During the COVID-19 Pandemic Causing Undesirable Post-Operative Complications
Development of dilution protocols of DCA for distribution over larger surface areas while maintaining efficacy could meaningfully expand the arsenal of safe in-office body sculpting techniques in Expanding Use of Deoxycholic Acid for Body Contouring: An Experimental Model for Dilution
In addition, make sure to check out our supplement, Skincare for Cancer Patients and Survivors: An increasing number of patients survive or are living with cancer. Anticancer treatments frequently have cutaneous adverse events (cAEs) that may severely impact patients’ quality of life and interrupt anticancer treatment. The US Cutaneous Oncodermatology Management (USCOM) project aims to improve cancer patients’ and survivors’ quality of life by offering tools for preventing and managing cAEs.
Did you enjoy this JDD Highlights article? Find more here.
